Chardan Healthcare Acquisition Corp.

Status: Deal Closed
U=S+W W=S/2@11.5
IPO Proceeds, $M $70.00M
IPO Date Dec 14, 2018
CEO Jonas Grossman
Left Lead Chardan
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare
IPO Geography Global
Target Company BioMx
Deal Announced Jul 16, 2019
Deal Size, $M $253.75M
Deal Sector Healthcare
Deal Geography EEMEA
SEC Filings www.sec.gov
Approval Vote Oct 23, 2019
Amendment Vote TBD
Closing Date Oct 28, 2019
Formerly CHAC PHGE PHGE.W

Sign up for Free Trial

No credit card required

Sign in for more on Chardan Healthcare Acquisition Corp.:

  • Structure and cap table
  • 8 directors & officers
  • 25 filings and events
  • 3 underwriters
  • 2 deal advisors
  • 5 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Gbola Amusa 44 Executive Chairman of the Board
Jonas Grossman 44 President, CEO & Director
George Kaufman 42 CFO, Head of Strategy & Director
Michael Rice 53 Director
Richard Giroux 46 Director
Matthew Rossen 41 Director
Dr. Eric Kusseluk 43 Director
Sukumar Nagendran, MD Special Advisor

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Chardan BR 6,965,000 units
Brookline Capital Markets 35,000
B. Riley FBR 1
7,000,001 units
Up-Front UW fee 0.71 %
Deferred UW fee 0.00 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 25 filings.

Shareholders

Sign in to view shareholders 13F filing data.